Alto Pharmacy Valuation Analysis: Latest Market Insights & Trends

Hill Chart Shape

Alto Pharmacy Valuation and Overview

Alto Pharmacy
Sectors
Health, Transportation, Logistics
Headquarters
Bay Area, CA, USA
CEO
Alicia Boler Davis
Alto Pharmacy shares, as of Apr 21, 2025, are valued at a price per share implying an approximate 2.49% discount to their to their last round.Alto Pharmacy shares, as of Apr 21, 2025, are valued at a price per share implying an approximate 2.49% discount to their to their last round. Alto Pharmacy shares, as of April 21, 2025, are valued at a price per share implying an approximate +21.5% relative to the most recent significant secondary market activity in September 2024, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Alto Pharmacy's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Alto Pharmacy.
Register today to view the full report, with more in-depth details and analytics
Series F Valuation
Latest funding round
$800.0M
XXXXX
2023-06-27
XX-XX-XXXX
PM Insights Implied Valuation
$780.05M
2025-04-21
AV Implied Valuation
XXXXX
XX-XX-XXXX
Change since Last Round
-2.49%
2023-06-27 ➞ 2025-04-21
Change since Last Round
XXXXX
XX-XX-XXXX
Secondary Activity
XXXXX

Business Partnerships

Targeted Impact

Who Will Benefit?

What Comes Next?

Alto Pharmacy Growth Timeline

No items found.

Alto Pharmacy and Competition

For additional insights and information on Alto Pharmacy, contact us today to access the full ApeVue report.
Request the full report

Alto Pharmacy Market Inteligence Snapshot

Alto Pharmacy Annual Revenue & Year-Over-Year Growth Rate

Alto Pharmacy Secondary Market ROI (Return on Investment)

Alto Pharmacy shares, as of April 21, 2025, are valued at a price per share implying an approximate +21.5% relative to the most recent significant secondary market activity in September 2024, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Alto Pharmacy's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Alto Pharmacy.

Alto Pharmacy Bid-Ask Volume Ratios (Private Secondary Market)

Alto Pharmacy Mutual Fund Valuations (NAV)

Alto Pharmacy Funding Rounds & Cap Table Details

PM Insights tracks detailed primary funding rounds and verifies cap table directly from original filings for Alto Pharmacy. Alto Pharmacy raised $120.0M in its Series F on June 27, 2023, with a price per share reflecting a post-money valuation of $800.0M, according to PM Insights' market data.
Register today to view the full report, with more in-depth details and analytics:
Access the full report
Register today to view the full Alto Pharmacy report, with more in-depth details and analytics:
Access the full Alto Pharmacy report

Ready to see it in action?

Schedule a demo with one of our experts